Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Rules of evidence for cancer molecular-marker discovery and validation.

Literature DB >> 15057290

Rules of evidence for cancer molecular-marker discovery and validation.

David F Ransohoff¹.

Abstract

Entities: Disease

Mesh：

Substances：
Biomarkers, Tumor

Year: 2004 PMID： 15057290 DOI： 10.1038/nrc1322

Source DB: PubMed Journal: Nat Rev Cancer ISSN： 1474-175X Impact factor: 60.716

Keyword Cloud
Cited

× No keyword cloud information.

129 in total

1. Large scale evidence and replication: insights from rheumatology and beyond.

Authors: J P A Ioannidis
Journal: Ann Rheum Dis Date: 2004-09-30 Impact factor: 19.103

2. STrengthening the reporting of OBservational studies in Epidemiology-Molecular Epidemiology (STROBE-ME): an extension of the STROBE statement.

Authors: Valentina Gallo; Matthias Egger; Valerie McCormack; Peter B Farmer; John P A Ioannidis; Micheline Kirsch-Volders; Giuseppe Matullo; David H Phillips; Bernadette Schoket; Ulf Stromberg; Roel Vermeulen; Christopher Wild; Miquel Porta; Paolo Vineis
Journal: Eur J Epidemiol Date: 2011-10-29 Impact factor: 8.082

3. Statistical contributions to proteomic research.

Authors: Jeffrey S Morris; Keith A Baggerly; Howard B Gutstein; Kevin R Coombes
Journal: Methods Mol Biol Date: 2010

Review 4. Biomarkers and surrogate end points--the challenge of statistical validation.

Authors: Marc Buyse; Daniel J Sargent; Axel Grothey; Alastair Matheson; Aimery de Gramont
Journal: Nat Rev Clin Oncol Date: 2010-04-06 Impact factor: 66.675

5. Metabolic signatures of exercise in human plasma.

Authors: Gregory D Lewis; Laurie Farrell; Malissa J Wood; Maryann Martinovic; Zoltan Arany; Glenn C Rowe; Amanda Souza; Susan Cheng; Elizabeth L McCabe; Elaine Yang; Xu Shi; Rahul Deo; Frederick P Roth; Aarti Asnani; Eugene P Rhee; David M Systrom; Marc J Semigran; Ramachandran S Vasan; Steven A Carr; Thomas J Wang; Marc S Sabatine; Clary B Clish; Robert E Gerszten
Journal: Sci Transl Med Date: 2010-05-26 Impact factor: 17.956

Review 10. Current status and prospects of clinical proteomics studies on detection of colorectal cancer: hopes and fears.

Authors: M E de Noo; R A E M Tollenaar; A M Deelder; L H Bouwman
Journal: World J Gastroenterol Date: 2006-11-07 Impact factor: 5.742

Rules of evidence for cancer molecular-marker discovery and validation.

1. Large scale evidence and replication: insights from rheumatology and beyond.

2. STrengthening the reporting of OBservational studies in Epidemiology-Molecular Epidemiology (STROBE-ME): an extension of the STROBE statement.

3. Statistical contributions to proteomic research.

Review 4. Biomarkers and surrogate end points--the challenge of statistical validation.

5. Metabolic signatures of exercise in human plasma.

Review 6. Statistical considerations on prognostic models for glioma.

7. Molecular bias.

8. Assessing the quality and reproducibility of a proteomic platform for clinical stroke biomarker discovery.

Review 9. The biology of human lymphoid malignancies revealed by gene expression profiling.

Review 10. Current status and prospects of clinical proteomics studies on detection of colorectal cancer: hopes and fears.